US revokes emergency use of malaria drugs vs. coronavirus

Local News

FILE – In this April 9, 2020 file photo, a chemist displays hydroxychloroquine tablets in New Delhi, India. U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19. The Food and Drug Administration said Monday, June 15 that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. (AP Photo/Manish Swarup, File)

WASHINGTON (AP) – U.S. regulators are revoking emergency authorization for malaria drugs for treating COVID-19. The Food and Drug Administration said Monday that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus.

Citing reports of heart complications, the FDA said the drugs pose a greater risk to patients than any potential benefits. The decades-old drugs, also prescribed for lupus and rheumatoid arthritis, can cause heart rhythm problems, severely low blood pressure and muscle or nerve damage.

Stay with News 2 for continuing coverage of the COVID-19 Pandemic.

MORE COVERAGE

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.



Don't Miss

Trending Stories